Defining critical pathways for neuronal loss and dysfunction in Parkinsons disease and stroke
PARK, David S
8 enregistrements totalisant 10,764,788.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $10,764,788 | 8 enregistrements |
Enregistrements
Insights into Parkinson's disease, Crohn's disease, and leprosy: a common role for LRRK2
"Mitochondrial Dysfunction and Susceptibility to Parkinson's disease: New Models of Pathogenetic Interactions"
Role of cell cycle signals in neuronal death
Targeting glucocerebrosidase for disease-modifying treatments in Parkinson disease
Mechanisms of DJ-1 in an aging model of PD
Cellular Bioenergetics in Neurodegenerative Diseases: A system-based pathway and target analysis.
GBA1 mutations in Parkinson's disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention.